Nick van Es/LinkedIn; Faizan Khan/University of Calgary
Mar 7, 2026, 15:52
Faizan Khan: The Importance of Cancer Site in Bleeding Risk Stratification for Cancer-Associated VTE
Faizan Khan, CIHR Banting Postdoctoral Fellow at University of Calgary, shared on LinkedIn about a recent article he and Nick van Es co-authored, adding:
”In a new publication from my Banting Canada postdoctoral fellowship out today in The Lancet Haematology, Nick van Es and I highlight the importance of considering different cancer sites for bleeding risk stratification in patients with cancer-associated Venous Thromboembolism.”
Title: Predictors of clinically relevant bleeding during extended anticoagulation for cancer-associated VTE
Authors: Faizan Khan, Nick van Es
Read the Full Article on The Lancet Haematology
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 11, 2026, 12:58Joseph R. Shaw: Beyond Predictable Pharmacokinetics in DOAC Therapy
-
Jun 11, 2026, 12:40Khechar N Paudel: The Nepal Stroke Project Brings Evidence-Based Stroke Care to Remote Communities
-
Jun 11, 2026, 12:35Sergey Badalyan: EHA2026 Opening Ceremony – The Importance of Building Communities, Not Projects
-
Jun 11, 2026, 12:15Welcome to EHA 2026
-
Jun 11, 2026, 08:35Mohamed Reda: CBC Report – More Than Just Numbers
-
Jun 11, 2026, 07:59Uday Sankar Akash Vankayala: Key Findings on IBD-Associated VTE Phenotypes and Inpatient Burden
-
Jun 11, 2026, 07:41Zia Ullah: Hidden Cerebral Venous Sinus Thrombosis After Dengue Recovery
-
Jun 11, 2026, 07:24Aaron Rodriguez Calienes: RESISTANT Registry Provides Reassuring Safety Data for Acute Intracranial Stenting
-
Jun 11, 2026, 07:17Mbunya. S. Misiani: From the WFH Congress to Meaningful Change for Patients with Bleeding Disorders Worldwide